← All stocks

Cullinan Therapeutics, Inc.

CGEM Scheduled selling only

CIK 0001789972 #2364 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$172.56K

$0.00 on a plan · $172.56K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$172.56K

$0.00 against sales at will

By person

7 insiders · 1 transaction

12.0×

Nadim Ahmed holds 12.0 times base salary in stock. $8.43M of shares against $698.48K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadim Ahmed last reported holding, valued at $21.57, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michaelson Jennifer

Chief Scientific Officer

—

$172.56K (1) scheduled

−$172.56K

158,844

0.2468%

$3.43M

+34.7%

Lynx1 Capital Management LP entity

10% owner

—

8,963,500

13.93%

$193.34M

+26.4%

AHMED NADIM

President and CEO

—

390,803

0.6073%

$8.43M

+43.9%

Savill Corrine

Chief Business Officer

—

240,990

0.3745%

$5.20M

+18.4%

Jones Jeffrey Alan

Chief Medical Officer

—

159,968

0.2486%

$3.45M

+34.8%

SUMER JACQUELYN L

Chief Legal Officer

—

130,559

0.2029%

$2.82M

+35.8%

Fenton Mary Kay

Chief Financial Officer

—

127,921

0.1988%

$2.76M

+6,293%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Michaelson Jennifer

8 Sep 2026

Chief Scientific Officer

Sold after exercise

8,000

$21.57

$172.56K

Show all 1 transactions →

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 4,000

History held since 11 Jan 2021